相关实验视频
Updated: Jun 7, 2025

04:23
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
241
癌症患者的骨髓缩症:系统性审查和元分析
Chien-Chieh Wang1, Hsuan-Chih Liu2,3, Wen-Li Lin4
1Department of Orthopedics, Chi Mei Medical Center, Tainan City, Taiwan, R.O.C.
Medicine
|November 13, 2024
概括
骨质疏松症和骨质疏松症与癌症患者的无疾病生存率较差有关. 这些条件预示着更糟糕的结果,突出了它们在癌症护理和老龄化人口中的重要性.
科学领域:
- 老年瘤学 老年瘤学
- 癌症的生存率 癌症的生存率
- 骨和肌肉健康的健康问题
背景情况:
- 骨质疏松症,骨质疏松症和骨质疏松症的组合,在老年人群中越来越多地被认可.
- 它与较高的骨折风险和较差的老年人结局有关,特别是那些接受癌症治疗的人.
研究的目的:
- 为了评估骨质疏松症对癌症患者整体存活率 (OS) 和无病存活率 (DFS) 的影响.
- 为了比较癌症患者与 osteosarcopenia 和没有的癌症患者之间的生存结果.
主要方法:
- 在五个主要的电子数据库 (Embase,PubMed,Web of Science,Scopus,CINAHL) 进行了系统的文献搜索,截至2024年2月.
- 对8项选定的研究进行了元分析,其中包括1608名参与者,以评估OS和DFS.
- 符合预先定义的标准的研究被纳入评估癌症患者的存活率与 osteosarcopenia 和没有.
主要成果:
- 患有骨质疏松症,骨疏松症或骨疏松症的患者与没有这些疾病的患者相比,表现出明显更糟糕的DFS.
- 骨质疏松症 (HR=1.70,P=0.01) 和骨质疏松症 (HR=2.17,P=0.0001) 被确定为DFS的独立预测因素.
- 单独 Sarcopenia 也与 DFS 有显著的关联,而没有检测到出版偏差.
结论:
- 骨质疏松症和骨质疏松症与癌症患者的DFS降低有关.
- 这些发现表明,这些情况是癌症护理中的重要预后因素.
- 需要进一步的研究来证实这些结果,特别是关于整体存活率.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K

